First Trust Advisors LP Harrow Health, Inc. Transaction History

First Trust Advisors LP

  • $101 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 12, 2022
SELL
$5.75 - $7.74 $4,720 - $6,354
-821 Reduced 2.21%
36,301 $264,000
Q1 2022

May 13, 2022
SELL
$6.77 - $8.66 $14,589 - $18,662
-2,155 Reduced 5.49%
37,122 $253,000
Q4 2021

Feb 08, 2022
BUY
$8.5 - $12.0 $41,352 - $58,380
4,865 Added 14.14%
39,277 $339,000
Q3 2021

Nov 15, 2021
BUY
$6.99 - $10.6 $240,539 - $364,767
34,412 New
34,412 $313,000

Others Institutions Holding HROW

# of Institutions
177
Shares Held
21.4M
Call Options Held
845K
Put Options Held
717K
View Full List

About HARROW HEALTH, INC.

HROW Quotes by TradingView
  • Ticker HROW
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 27,070,000
  • Market Cap $992M
  • Description
  • Harrow Health, Inc. operates as an ophthalmic-focused healthcare company. The company owns ImprimisRx, an ophthalmology outsourcing and pharmaceutical compounding business; and DEXYCU for the treatment of post-operative inflammation. The company also holds equity interests in Surface Ophthalmics, Inc., a clinical-stage pharmaceutical company tha...
More about HROW
Track This Portfolio

Track First Trust Advisors LP Portfolio

Follow First Trust Advisors LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of First Trust Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on First Trust Advisors LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email